Physician profile
Richard A Matano
NPI 1629167176
$13,038.99
in general payments reported to CMS, 2019-2025
18 companies · $8,028 in 2025
The $8,028 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $268 · 2021: $652 · 2022: $2,519 · 2023: $691 · 2024: $219 · 2025: $8,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,120 · Consulting Fee: $3,000 · Travel and Lodging: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,119.55 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $1,818.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $6,212.96 | 2020-2025 | Afx2 Bifurcated Endograft System, Endocross Device, Torus Stent Graft System |
| Silk Road Medical, INC. | $2,019.85 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $1,777.55 | 2021-2025 | Endurant Iis, Hawkone, Valiant Captivia |
| W. L. Gore & Associates, INC. | $1,465.22 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic Vascular, INC. | $687.55 | 2019-2020 | |
| Bolton Medical INC | $222.69 | 2022 | |
| Livanova USA, INC. | $204.14 | 2019-2021 | |
| Cook Medical LLC | $70.74 | 2021-2024 | Zilver Ptx, Rosen, Cook Celect |
| Inari Medical, INC. | $68.47 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $64.20 | 2020-2022 | |
| Chiesi USA, INC. | $59.89 | 2024-2025 | Cleviprex, Kengreal |
| Cumberland Pharmaceuticals, INC. | $49.35 | 2022-2023 | Caldolor |
| Penumbra, INC. | $36.42 | 2021-2023 | Penumbra System, Indigo System |
| Terumo Medical Corporation | $27.97 | 2021 | |
| Angiodynamics, INC. | $25.90 | 2025 | Angiovac |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $22.42 | 2019 | |
| Merck Sharp & Dohme LLC | $15.81 | 2022 | |
| Cardiovascular Systems INC. | $7.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Matano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.